Saltar al contenido
Merck

MAB1302

Mouse Anti-Human IgG Antibody, clone HP6017, Fc

clone HP6017, Chemicon®, from mouse

Sinónimos:

Anti-CD32, Anti-CD32B, Anti-FCG2, Anti-FCGR2, Anti-FCGR2C, Anti-FcGRIIB, Anti-FcRII-c, Anti-FcgammaRIIb, Anti-IGFR2

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Acerca de este artículo

UNSPSC Code:
12352203
NACRES:
NA.46
eCl@ss:
32160702

Documentos clave

Ver Toda la documentación
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle

Nombre del producto

Mouse Anti-Human IgG Antibody, clone HP6017, Fc, clone HP6017, Chemicon®, from mouse

biological source

mouse

antibody form

purified immunoglobulin

antibody product type

secondary antibodies

clone

HP6017, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable
radioimmunoassay: suitable
western blot: suitable

isotype

IgG2aκ

NCBI accession no.

NM_001002273.1
NM_001002274.1
NM_001002275.1
NM_004001.3

UniProt accession no.

P31994

shipped in

wet ice

target post-translational modification

unmodified

Quality Level

100

Gene Information

human ... FCGR2B(2213)

Categorías relacionadas

Application

Detect Human IgG using this Mouse anti-Human IgG Antibody, clone HP6017, Fc validated for use in ELISA, RIA & WB.
Research Category
Secondary & Control Antibodies
Research Sub Category
Fragment Specific Secondary Antibodies
Useful as both a capture antibody and a detection antibody for human IgG Fc (Papadea et al., 1985; Hamilton, et al., 1987).

ELISA

Radio-immunoassay (RIA)

Immunobloting.

Optimal working dilutions must be determined by end user.

Biochem/physiol Actions

Human IgG Fc fragment. ELISA Specificity: (Hamilton et al., 1987)

human IgG subclass 1 100%

human IgG subclass 2 100%

human IgG subclass 3 100%

human IgG subclass 4 100%

human IgG Pan 100%

human IgG Fc 100%

human IgG Fab .12%



Isoelectric Focusing: mean pI 8.0

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Immunogen

Epitope: Fc fragment

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Replaces: CBL102

Physical form

Format: Purified
Purified immunoglobulin. Liquid in 0.02M PB, 0.25M NaCl with 0.1% sodium azide, pH=7.6.

Preparation Note

Maintain at 2-8°C in undiluted aliquots for up to 12 months.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

¿No encuentra el producto adecuado?  

Pruebe nuestro Herramienta de selección de productos.

Clase de almacenamiento

10 - Combustible liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Gunnveig Grodeland et al.
Journal of immunology (Baltimore, Md. : 1950), 197(9), 3575-3585 (2016-09-28)
It has been difficult to translate promising results from DNA vaccination in mice to larger animals and humans. Previously, DNA vaccines encoding proteins that target Ag to MHC class II (MHC-II) molecules on APCs have been shown to induce rapid
Miguel Ángel Muñoz-Alía et al.
PLoS pathogens, 17(2), e1009283-e1009283 (2021-02-04)
The frequent overexpression of CD46 in malignant tumors has provided a basis to use vaccine-lineage measles virus (MeV) as an oncolytic virotherapy platform. However, widespread measles seropositivity limits the systemic deployment of oncolytic MeV for the treatment of metastatic neoplasia.
Kartik A Shah et al.
Biotechnology and bioengineering, 112(12), 2624-2629 (2015-06-03)
Monoclonal antibodies (mAbs) that bind and neutralize human pathogens have great therapeutic potential. Advances in automated screening and liquid handling have resulted in the ability to discover antigen-specific antibodies either directly from human blood or from various combinatorial libraries (phage

Número de artículo de comercio global

SKUGTIN
MAB130204053252360756

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico